InsulintestName The C-peptide suppression test is a crucial diagnostic tool used to evaluate pancreatic beta-cell function and investigate conditions characterized by abnormal insulin secretion, particularly hypoglycemia and insulinoma. This test measures how effectively the body suppresses endogenous insulin production in response to induced hypoglycemia. By assessing C-peptide levels, which are released in equimolar amounts with insulin, clinicians gain insight into the body's insulin secretory reserve and can differentiate between various causes of low blood glucose.Thistesthas been used in cases in which the 72-hour diagnostic fast is inconclusive.1,2Production ofC-peptideby normal subjects is generallysuppressed... The test is particularly valuable in diagnosing insulinoma, a rare tumor of the pancreas that secretes excessive insulin.010108: C-Peptide
C-peptide is a byproduct of insulin synthesis. When proinsulin, a precursor molecule, is cleaved to produce insulin, C-peptide is released simultaneously into the bloodstream. Therefore, measuring C-peptide levels provides an indirect yet reliable indicator of endogenous insulin productionC-Peptide Test: What It Is, Purpose, Procedure & Results. This distinction is vital because exogenous insulin (administered as medication) does not contain C-peptide. In healthy individuals, when blood glucose levels drop, the body naturally suppresses insulin secretion to prevent further hypoglycemia.Thistesthas been used in cases in which the 72-hour diagnostic fast is inconclusive.1,2Production ofC-peptideby normal subjects is generallysuppressed... The C-peptide suppression test leverages this physiological response.
The core principle of the C-peptide suppression test involves inducing a state of hypoglycemia, typically by administering an insulin infusion. This controlled drop in blood glucose simulates a hypoglycemic episode. In individuals with normal pancreatic function, the low blood glucose levels should trigger a suppression of endogenous insulin secretion. This suppression is reflected in a corresponding decrease in C-peptide levels.
During the test, blood samples are drawn at baseline and at various intervals after the insulin injection.C-peptideis used as a test of β-cell functionin a variety of conditions including type 1 diabetes, and to aid in the differential diagnosis of hypoglycemia. By measuring the C-peptide levels in these samples, clinicians can observe how effectively the body is able to reduce its own insulin production. An impaired suppression of endogenous insulin secretion, as evidenced by persistently high or inadequately suppressed C-peptide levels despite hypoglycemia, is a key indicator that something is amiss.C-Peptide Test
One of the primary applications of the C-peptide suppression test is in the diagnosis of insulinomaC-Peptide: Reference Range, Interpretation, Collection and .... Patients with insulinoma often experience recurrent episodes of hypoglycemia because the tumor autonomously produces and secretes excessive insulin, irrespective of blood glucose levels. In such cases, the C-peptide suppression test will reveal a failure of C-peptide levels to decrease appropriately during insulin-induced hypoglycemia, indicating inappropriate insulin secretionLab Dept: Chemistry Test Name: C-PEPTIDE, SERUM.
Beyond insulinoma, the test is also useful for diagnosing other causes of unexplained hypoglycemia, including factitious hypoglycemia, which can occur due to the surreptitious administration of insulin. By measuring C-peptide, clinicians can differentiate between hypoglycemia caused by the body's own excessive insulin production versus externally administered insulin.
While the C-peptide suppression test is primarily focused on investigating hypoglycemia, C-peptide measurements, in general, play a role in understanding diabetes. A standard C-peptide test, often performed fasting or after a meal, can help differentiate between Type 1 and Type 2 diabetesEfficacy of insulin and C-peptide suppression test using a .... In Type 1 diabetes, the pancreas produces very little or no insulin, leading to low C-peptide levels. In contrast, individuals with Type 2 diabetes, especially in the earlier stages, often have normal or even high C-peptide levels, indicating that their pancreas is still producing insulin, albeit perhaps inefficiently2025年6月25日—A C-peptide testmeasures C-peptide in your blood or urine. It can help find the cause of low blood glucose and guide diabetes treatment..
Several factors can influence the results of a C-peptide suppression test, including gender, age, and body mass index (BMI). Studies have assessed the effects of these variables on plasma C-peptide suppression during insulin-induced hypoglycemia to ensure accurate interpretation of test outcomes.作者：FJ Service·1977·被引用次数：45—During hypoglycemia induced by an infusion of porcine insulin,impaired suppression of endogenous insulin secretion as measured by C-peptidewas demonstrated in ... Understanding these nuances is crucial for precise diagnosis.
The C-peptide suppression test is an indispensable diagnostic procedure for evaluating pancreatic beta-cell function and identifying the underlying causes of hypoglycemia, particularly insulinoma. By directly assessing the body's ability to suppress endogenous insulin secretion in response to induced hypoglycemia, this test provides critical information that aids clinicians in making accurate diagnoses and guiding appropriate treatment strategies. Its ability to distinguish between endogenous and exogenous insulin production further solidifies its importance in the investigation of complex metabolic disorders.
Join the newsletter to receive news, updates, new products and freebies in your inbox.